With the analysis among 112 patents, we discovered top 47 key players by total patent application. AstraZeneca Pharmaceutical Co., Ltd., Oncternal Therapeutics, Inc., Lunan Pharmaceutical Group Co., Ltd. are dominant in this area. They take 40.18% of the total patent filing.
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 30
Oncternal Therapeutics, Inc.
California, United States
Patent: 8
Lunan Pharmaceutical Group Co., Ltd.
Shandong Sheng, China
Patent: 7
Calithera Biosciences, Inc.
California, United States
Patent: 6
Andhra Pradesh, India
Patent: 4
Blueprint Medicines Corp.
Massachusetts, United States
Patent: 4
Ono Pharmaceutical Co., Ltd.
Taiwan Province, China
Patent: 4
The General Hospital Corp.
Massachusetts, United States
Patent: 4
Zhongshan Yi Antai Pharmaceutical Technology Co., Ltd.
Guangdong Sheng, China
Patent: 4
With the analysis among 3 patents, we discovered top 2 start-ups by total patent application.
Institut National de la Santé et de la Recherche Médicale
California, United States
Patent: 1
With the analysis among related 159 patents applied in the last 5 years. We discover 72 most active companies in this area. The fast-growing AstraZeneca Pharmaceutical Co., Ltd., The Board of Regents of The University of Texas System, Oncternal Therapeutics, Inc. take 30.82% of patent filing during this period.
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 23
The Board of Regents of The University of Texas System
Texas, United States
Patent: 18
Oncternal Therapeutics, Inc.
California, United States
Patent: 8
Lunan Pharmaceutical Group Co., Ltd.
Shandong Sheng, China
Patent: 7
Calithera Biosciences, Inc.
California, United States
Patent: 6
Guangdong Sheng, China
Patent: 5
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 5
Kyoto Prefectural Public University Corp.
Ono Pharmaceutical Co., Ltd.
The General Hospital Corp.
Massachusetts, United States
Patent: 4
With the analysis among related 159 patents in last 5 years, we discover 69 new entrants. The Board of Regents of The University of Texas System, Oncternal Therapeutics, Inc., Lunan Pharmaceutical Group Co., Ltd. are the most active new entrants in this area.
The Board of Regents of The University of Texas System
Texas, United States
Patent: 18
Oncternal Therapeutics, Inc.
California, United States
Patent: 8
Lunan Pharmaceutical Group Co., Ltd.
Shandong Sheng, China
Patent: 7
Calithera Biosciences, Inc.
California, United States
Patent: 6
Guangdong Sheng, China
Patent: 5
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 5
Kyoto Prefectural Public University Corp.
Ono Pharmaceutical Co., Ltd.
The General Hospital Corp.
Massachusetts, United States
Patent: 4
Taiwan Province, China
Patent: 4
With the analysis among 61 patents, we discovered top 21 universities and scientific research institutions by total patent application. Jinan University, Shanghai Institute of Materia Medica Chinese Academy of Sciences, Hangzhou Normal University are dominant in this area. They take 45.90% of the total patent filing.
Guangdong Sheng, China
Patent: 5
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 5
Hangzhou Normal University
Zhejiang Sheng, China
Patent: 3
Shanghai University of Engineering Science
Shanghai Shi, China
Patent: 2
Hunan Sheng, China
Patent: 1
Zhejiang Sheng, China
Patent: 1
Beijing Normal University
Beijing Shi, China
Patent: 1
University of Shanghai for Science & Technology
Shanghai Shi, China
Patent: 1
Jiangsu Sheng, China
Patent: 1
SOMERSET, United Kingdom
Patent: 1